SCHEMBL25969306

SCHEMBL25969306

NC(=O)Cn1nc(-c2ccc(Cl)cc2)ccc1=O

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.66
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
MAPT P10636 1/20 0.58
ALDH1A1 P00352 4/20 0.57
KDM4E B2RXH2 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
HSD17B10 Q99714 3/20 0.57
USP2 O75604 1/20 0.57
TP53 P04637 1/20 0.57
ALOX15 P16050 1/20 0.57
POLB P06746 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25969107 0.85 KDM4E (0.69) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL26363706 0.85 HTT (0.64) TSHRMEN1KMT2AALDH1A1KDM4E
SCHEMBL30295828 0.82 HDAC1 (0.59) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL29457946 0.82 LMNA (0.64) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL23297300 0.80 HDAC1 (0.65) TSHRMEN1KMT2AMAPTKDM4E
SCHEMBL17504167 0.79 MEN1 (0.68) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL23495266 0.79 MAPT (0.64) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL23297284 0.78 MEN1 (0.60) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL18169206 0.78 KDM4E (0.65) TSHRMEN1KMT2AKDM4EHSD17B10
SCHEMBL23495412 0.78 MAPT (0.59) TSHRMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4248972-A2 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2023-09-27 EP disclosed
EP-3877052-B1 PYRIDAZINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS INC (US) 2023-08-16 EP disclosed